XORTX Therapeutics(NASDAQ:XRTX) 
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant pol...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.92
H 0.95
L 0.85
C 0.90
V 17,440
10EMA 0.90
20EMA 0.90
60EMA 0.90
120EMA 0.90
250EMA 0.90